Showing results (41-50 of 140) with videos related to
Sort By:
Pageof 14
European Journal of Haematology. Supplementum|August 7, 2001
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacyS J Proctor, P R Taylor, B Angus, et al.European Journal of Haematology. Supplementum|August 7, 2001
The role of ifosfamide in the treatment of relapsed and refractory lymphomaM Reiser, H Bredenfeld, A Engert, et al.European Journal of Haematology. Supplementum|April 9, 2008
Emerging strategies to treat chronic immune thrombocytopenic purpuraAdrian NewlandEuropean Journal of Haematology. Supplementum|January 1, 1996
Meeting the challenge of systemic fungal infections in cancer: nursing implicationsJ AntrumEuropean Journal of Haematology. Supplementum|January 1, 1989
Treatment of painful bone lesions and hypercalcemiaE Ascari, G Attardo-Parrinello, G MerliniEuropean Journal of Haematology. Supplementum|July 13, 2005
Overview of the Sixth International Symposium on Hodgkin's disease--recent advances in basic and clinical trialsAndreas Josting, Cordula Heidecke, Volker DiehEuropean Journal of Haematology. Supplementum|July 13, 2005
An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programmeStephen J Proctor, Jo White, Gail L JonesEuropean Journal of Haematology. Supplementum|July 13, 2005
Immunotherapy of Hodgkin's lymphomaP Borchmann, R Schnell, A EngertEuropean Journal of Haematology. Supplementum|February 10, 2009
Characteristics of immune thrombocytopenic purpura: a guide for clinical practiceDrew ProvanEuropean Journal of Haematology. Supplementum|July 13, 2005
Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, ItalyPeter Mauch, Andrea Ng, Berthe Aleman, et al.Pageof 14